Patienten mit Diabetes mellitus und terminaler Niereninsuffizienz – Peritonealdialyse ist eine medizinisch sinnvolle Therapieoption

doi:10.1055/s-0030-1267324

Dialyse aktuell, Inhaltsverzeichnis

Dialyse aktuell 2010; 14(7): 402-403
DOI: 10.1055/s-0030-1267324

Forum der Industrie

Patienten mit Diabetes mellitus und terminaler Niereninsuffizienz – Peritonealdialyse ist eine medizinisch sinnvolle Therapieoption

Abstract

Volltext

Referenzen

Literatur

01 Frei U , Schober-Halstenberg H J. Nierenersatztherapie in Deutschland. Bericht über Dialysebehandlung und Nierentransplantation in Deutschland 2006/2007. Quasi-Niere 2007. Im Internet:. http://www.bundesverband-niere.de/files/QuaSi-Niere-Bericht_2006-2007.pdf
02 Covic A , Bammens B , Lobbedez T , et al . Educating end-stage renal disease patients on dialysis modality selection: a clinical advice from European Renal Best Practice (ERBP) Advisory Board. Nephrol Dial Transplant. 2010; 25 1757-1759
03 Mendelssohn D C, Mujais S K, Soroka S D, et al . A prospective evaluation of renal replacement therapy modality eligibility. Nephrol Dial Transplant. 2009; 24 555-561
04 Li P K, Chow K M. Peritoneal dialysis patient selection: characteristics for success. Adv Chronic Kidney Dis. 2009; 16 160-168
05 Lee C C, Sun C Y, Wu M S. Long-term modality-related mortality analysis in incident dialysis patients. Perit Dial Int. 2009; 29 182-190
06 Heaf J G, Lokkehaard H , Madsen M . Initial survival advantage of peritoneal dialysis relative to haemodialysis. Nephrol Dial Transplant. 2002; 17 112-117
07 Vonesh E F, Snyder J J, Foley R N, Collins A J. The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney Int. 2004; 66 2389-2401
08 Fußhöller A , Rump L C. Peritonealdialyse. Mehr Unabhängigkeit für Dialysepatienten mit Diabetes. Diabetologe. 2009; 5 549-556
09 Kuriyama S . Peritoneal dialysis in patients with diabetes: are the benefits greater than the disadvantages?. Perit Dial Int. 2007; 27 (Suppl 2) S190-S195
10 Holmes C J, Shockley T R. Strategies to reduce glucose exposure in peritoneal dialysis patients. Perit Dial Int. 2000; 20 (Suppl. 2) S37-S41
11 le Pool C Y, van Ittersum F J, Valentijn R M, et al . The NEPP-PD regimen results in lower plasma levels of the glucose degradation product (GDP) 3-Deoxyglucosone in CAPD patients. Perit Dial Int. 2004; 24 (Suppl 1) S20
12 Paniagua R , Ventura M D, Avila-íaz M , et al . Icodextrin improves metabolic and fluid management in high and high-average transport diabetic patients. Perit Dial Int. 2009; 29 422-432
13 Marshall J , Jennings P , Scott A , et al . Glycemic control in diabetic CAPD patients assessed by continuous glucose monitoring system (CGMS). Kidney Int. 2003; 64 1480-1486